RYTFX
Price
$8.22
Change
+$0.07 (+0.86%)
Updated
Aug 21 closing price
Net Assets
941.46M
SSGSX
Price
$53.55
Change
+$0.34 (+0.64%)
Updated
Aug 21 closing price
Net Assets
4.33B
Interact to see
Advertisement

RYTFX vs SSGSX

RYTFX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
RYTFX vs. SSGSX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTFX is a Hold and SSGSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.33B vs. RYTFX (941M). RYTFX pays higher dividends than SSGSX: RYTFX (0.65) vs SSGSX (0.52). RYTFX was incepted earlier than SSGSX: RYTFX (25 years) vs SSGSX (27 years). RYTFX (1.60) is less costly to investors than SSGSX (1.23). RYTFX is a more actively managed with annual turnover of: 59.00 vs. SSGSX (50.00). RYTFX has a lower initial minimum investment than SSGSX: RYTFX (2000) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 18.75 vs. RYTFX (4.21). SSGSX return over 5 years is better than : -0.19 vs. RYTFX (-21.89).
RYTFXSSGSXRYTFX / SSGSX
Total Expense Ratio1.491.23121%
Annual Report Gross Expense Ratio1.601.23130%
Fund Existence25 years27 years-
Gain YTD14.31319.82572%
Front LoadN/A6%-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets941M4.33B22%
Annual Yield % from dividends0.650.52126%
Returns for 1 year4.2118.7522%
Returns for 3 years16.2515.80103%
Returns for 5 years-21.89-0.1911,820%
Returns for 10 years-33.5936.80-91%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCPIX133.462.62
+2.00%
ProFunds UltraSector Health Care Inv
IVNCX22.680.17
+0.76%
Nomura Global Growth Fund Class C
PVMIX18.270.12
+0.66%
Principal MidCap Value I Inst
HSMRX15.600.09
+0.58%
Hartford Small Cap Value R3
JMVSX35.980.19
+0.53%
JPMorgan Mid Cap Value I